Abstract The National Kidney Foundation's Kidney Disease Outcomes Quality Initiative
(KDOQI) has provided evidence-based guidelines for hemodialysis vascular access since …

Surgically-created blood conduits used for chronic hemodialysis, including native
arteriovenous fistulas (AVFs) and synthetic AV grafts (AVGs), are the lifeline for kidney …

Although our understanding of the failure mechanism of vascular access for hemodialysis
has increased substantially, this knowledge has not translated into successful therapies …

Objective We reviewed our initial experience creating a percutaneous arteriovenous fistula
(pAVF) using a thermal resistance anastomosis device with proximal radial artery inflow …

Introduction Due to early and late failures that may occur with surgically created
hemodialysis arteriovenous fistulas (SAVF), post-creation procedures are commonly …

Background Percutaneous transluminal angioplasty (PTA) is the first line of treatment for
stenosis in the arteriovenous fistula (AVF) created to provide access for hemodialysis, but …

Rationale & Objective Reducing turbulent blood flow through dialysis arteriovenous fistulas
(AVFs) and radial stretching of their venous wall may attenuate hyperplasia and stenosis …

Despite arteriovenous fistulae (AVF) being the preferred vascular access for haemodialysis,
high primary failure rates (30-70%) and low one-year patency rates (40-70%) hamper their …

Sutureless anastomotic devices present several advantages over traditional suture
anastomosis, including expanded global access to microvascular surgery, shorter operation …

Percutaneous transluminal angioplasty (PTA) of stenotic arteriovenous fistulas (AVFs) is
performed to maintain optimal function and patency. The one-year patency rate is 60 …